Deena Shakir, Lux Capital general partner, joins ‘TechCheck’ to discuss her thoughts on health tech stocks and biotech names.

Deena Shakir, Lux Capital general partner, joins ‘TechCheck’ to discuss her thoughts on health tech stocks and biotech names.
written by
written by

Deena Shakir, Lux Capital general partner, joins ‘TechCheck’ to discuss her thoughts on health tech stocks and biotech names.

visit source
Text Link